JP MORGAN/CALL/BOSTON SCIENTIFIC/78/0.1/16.08.24 Share Price

Warrant

DE000JK673K1

Market Closed - Börse Stuttgart 11:41:43 31/05/2024 BST
0.37 EUR -5.13% Intraday chart for JP MORGAN/CALL/BOSTON SCIENTIFIC/78/0.1/16.08.24
1 month+5.71%
Date Price Change
31/05/24 0.37 -5.13%
30/05/24 0.39 +5.41%
29/05/24 0.37 -13.95%
28/05/24 0.43 -.--%
27/05/24 0.43 +2.38%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 11:41 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BOSTON SCIENTIFIC CORPORATION
Issuer J.P. Morgan
WKN JK673K
ISINDE000JK673K1
Date issued 15/04/2024
Strike 78 $
Maturity 16/08/2024 (75 Days)
Parity 10 : 1
Emission price 0.11
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.43
Lowest since issue 0.19
Delta0.48x
Omega 8.548
Premium8.83x
Gearing17.64x
Moneyness 0.9694
Difference Strike 2.39 $
Difference Strike %+3.06%
Spread 0.03
Spread %7.32%
Theoretical value 0.3950
Implied Volatility 35.84 %
Total Loss Probability 58.06 %
Intrinsic value 0.000000
Present value 0.3950
Break even 82.29 €
Theta-0.02x
Vega0.01x
Rho0.01x

Company Profile

Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Sector
-
More about the company

Ratings for Boston Scientific Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Boston Scientific Corporation

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
75.57 USD
Average target price
82.06 USD
Spread / Average Target
+8.59%
Consensus